HealthInvestor's Business Daily
Move Aside Retatrutide, Eli Lilly Just Beat Its Next-Gen Obesity Drug
Eli Lilly already beat its next-generation weight-loss drug, retatrutide, and it hasn't even hit the market. The post Move Aside Retatrutide, Eli Lilly Just Beat Its Next-Gen Obesity Drug appeared first on Investor's Business Daily.
Join the argument
House rules βComments load as you scroll.